Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Blood (2016) 127 (13): 1656–1665.

https://doi.org/10.1182/blood-2015-10-676924

Published: 2016

Includes: Supplemental data

Journal Articles

Azacitadine and Low-Dose Gemtuzumab Ozogamicin for the Treatment of Poor-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Relapsed, Refractory Disease.

Laura C Michaelis, MD, Danielle Shafer, DO, Kevin Barton, MD, Tulio Rodriguez, MD, Scott Smith, M.D., Ph.D, Patrick Stiff, MD, Sucha Nand, MD

Blood (2009) 114 (22): 1034.

https://doi.org/10.1182/blood.V114.22.1034.1034

Published: 2009

Journal Articles

Aprepitant Vs. Placebo Plus Oral Ondansetron and Dexamethasone for the Prevention of Nausea and Vomiting Associated with Highly Emetogenic Preparative Regimens Prior to Hematopoietic Stem Cell Transplantation: A Prospective, Randomized Double-Blind Phase III Trial.

Patrick Stiff, MD, Mary Fox-Geiman, PharmD, Karen Kiley, MSN, NP, Nancy Porter, MSN, APN, Karen Rychlik, BA, Donna Fletcher-Gonzalez, PharmD, Amir Toor, MD, Scott E. Smith, MD, PhD, Tulio Rodriguez, MD

Blood (2009) 114 (22): 2267.

https://doi.org/10.1182/blood.V114.22.2267.2267

Published: 2009

Journal Articles

Standard Gvhd Prophylaxis Augmented with TNF-Inhibition in Alternative Donor HCT: Lower TNFR1 Levels Correlate with Better Outcomes.

Blood (2009) 114 (22): 43.

https://doi.org/10.1182/blood.V114.22.43.43

Published: 2009

Journal Articles

Phase III Randomized Stem Cell Mobilization Trial Comparing Standard Vs Double-Dose G-CSF Vs Standard Doses of G-CSF Plus GM-CSF in Hard to Mobilize Patients Undergoing An Autologous Hematopoietic Stem Cell Transplant (HSCT).

Elizabeth Berger, BA, Christopher Seet, MBBS, Mala Parthasarathy, MS, Tulio Rodriguez, MD, Scott E. Smith, MD, PhD, Amir Toor, MD, Mary Lee, RN, Cecilia Petrowsky, MSN, Mary Fox-Geiman, PharmD, Patrick Stiff, MD

Blood (2009) 114 (22): 3228.

https://doi.org/10.1182/blood.V114.22.3228.3228

Published: 2009

Journal Articles

A Phase III, Randomized, Double-Blind, Placebo-Controlled Comparative Trial of Pegfilgrastim Versus Filgrastim after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).

Aaron Gerds, MD, Mary Fox-Geiman, PharmD, Kevin Dawravoo, MD, Tulio Rodriguez, MD, Amir Toor, MD, Scott Smith, MD, PhD, Donna Fletcher-Gonzales, RPh, Chindo Hicks, PhD, Patrick Stiff, MD

Blood (2007) 110 (11): 479.

https://doi.org/10.1182/blood.V110.11.479.479

Published: 2007

Journal Articles

Amelioration of Late Complications Following Unrelated Donor Bone Marrow Transplantation When Anti-Thymocyte Globulin Is Used as a Part of Conditioning.

Matthew E. Adess, MD, Patrick Stiff, MD, Tulio Rodriguez, MD, John Norton, MS, Mala Parthasarthy, BS, Mary Fox-Geiman, PharmD, Scott Smith, MD, Amir Toor, MD

Blood (2006) 108 (11): 5319.

https://doi.org/10.1182/blood.V108.11.5319.5319

Published: 2006

Journal Articles

Successful Umbilical Cord Blood Transplants in Adults Who Received a Nucleated Cell Dose ≥ 1 X 10 7 Cells/kg Processed by a Post-Thaw Non-Wash Procedure.

Patrick Stiff, MD, Michael Shane, MS, Tulio Rodriguez, MD, Jared Klein, MD, Mala Parthasarathy, John Norton, Amir Toor, MD

Blood (2005) 106 (11): 2049.

https://doi.org/10.1182/blood.V106.11.2049.2049

Published: 2005

Journal Articles

Novel Combination of Gallium Nitrate, Rituximab and Dexamethasone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma or Transformed Follicular Lymphoma.

Scott E. Smith, MD, PhD, Patrick J. Stiff, MD, Tulio Rodriguez, MD, Amir Toor, MD, Jared Klein, MD

Blood (2005) 106 (11): 4755.

https://doi.org/10.1182/blood.V106.11.4755.4755

Published: 2005

Journal Articles

Allogeneic Stem Cell Transplantation (SCT) Using Rabbit-ATG (Thymoglobulin®) and Low Dose Total Body Irradiation (TBI): Favorable Outcomes with Unrelated Donors (URD).

Amir A. Toor, MD, Tulio Rodriguez, MD, Najeeb Mohideen, MD, Scott E. Smith, MD, Mala Parthasarathy, BS, John Norton, MS, Jared Klein, MD, Patrick J. Stiff, MD

Blood (2005) 106 (11): 1767.

https://doi.org/10.1182/blood.V106.11.1767.1767

Published: 2005

Journal Articles

Allogeneic Stem Cell Transplantation (SCT) Using Rabbit-ATG (Thymoglobulin®) and 2-Gy Total Body Irradiation (TBI): Reliable Early Engraftment with Minimal Acute Graft Vs. Host Disease (AGVHD).

Amir A. Toor, MD, Tulio Rodriguez, MD, Najeeb Mohideen, MD, Mala Parthasarathy, MS, Patrick J. Stiff, MD

Blood (2004) 104 (11): 2312.

https://doi.org/10.1182/blood.V104.11.2312.2312

Published: 2004

NARROW

Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure

Azacitadine and Low-Dose Gemtuzumab Ozogamicin for the Treatment of Poor-Risk Acute Myeloid Leukemia (AML) and Myelodysplastic Syndromes (MDS), Including Relapsed, Refractory Disease.

Aprepitant Vs. Placebo Plus Oral Ondansetron and Dexamethasone for the Prevention of Nausea and Vomiting Associated with Highly Emetogenic Preparative Regimens Prior to Hematopoietic Stem Cell Transplantation: A Prospective, Randomized Double-Blind Phase III Trial.

Standard Gvhd Prophylaxis Augmented with TNF-Inhibition in Alternative Donor HCT: Lower TNFR1 Levels Correlate with Better Outcomes.

Phase III Randomized Stem Cell Mobilization Trial Comparing Standard Vs Double-Dose G-CSF Vs Standard Doses of G-CSF Plus GM-CSF in Hard to Mobilize Patients Undergoing An Autologous Hematopoietic Stem Cell Transplant (HSCT).

A Phase III, Randomized, Double-Blind, Placebo-Controlled Comparative Trial of Pegfilgrastim Versus Filgrastim after Autologous Peripheral Blood Stem Cell Transplantation (PBSCT).

Amelioration of Late Complications Following Unrelated Donor Bone Marrow Transplantation When Anti-Thymocyte Globulin Is Used as a Part of Conditioning.

Successful Umbilical Cord Blood Transplants in Adults Who Received a Nucleated Cell Dose ≥ 1 X 10 7 Cells/kg Processed by a Post-Thaw Non-Wash Procedure.

Novel Combination of Gallium Nitrate, Rituximab and Dexamethasone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma, Mantle Cell Lymphoma or Transformed Follicular Lymphoma.

Allogeneic Stem Cell Transplantation (SCT) Using Rabbit-ATG (Thymoglobulin®) and Low Dose Total Body Irradiation (TBI): Favorable Outcomes with Unrelated Donors (URD).

Allogeneic Stem Cell Transplantation (SCT) Using Rabbit-ATG (Thymoglobulin®) and 2-Gy Total Body Irradiation (TBI): Reliable Early Engraftment with Minimal Acute Graft Vs. Host Disease (AGVHD).

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only